Bionic Eye Treatment, Cure of Blindness

by James R. Writer

Introduction - Artificial Eyesight and Vision

Other than the latest advancement in the domain of artificial eyesight and vision related innovations, other biomedical related fields have shown up multiple positive results for the eyes implant of an individual without eyesight or blindness. With numerous patients, who are having critical stages of any kind of retina disease, the popular cure is known as cellular based therapy. The techniques being used in the development of multiple ways in the field of stem cells, which may be a kind of exchanging the critical or not working retinal pigment epithelial (RPE) cells with embryonic stem cell (ESC)-derived. RPE cells are type of cells which saves and slightly recalibrate photoreceptor system in retinal degenerative diseases. The latest studies which modifies the photoreceptors straightly with sub retinal injections of exclusive front ends of photoreceptors from ESC have been detected. However, during the period of photoreceptors working, retinal gene cure can prove to be the most acceptable in order to save photoreceptor activities and avoid the cellular malfunctioning inside the structure of human eye.

Here in this write-up, we are into a very deep analysis on the current status with various retinal prosthetic functions in the process of eye vision. Precisely, the Argus® II and alpha-IMS functions are going to be analyzed in a broader way and the same way, where such functions have been mentioned in medical applications.

Image Analysis and Recording

There are two main methods of obtaining continuous visual inputs used by the current generation of retinal prostheses. One method uses an external video camera to capture the surrounding visual images, which are then processed in real time by computer algorithms and converted into electrical signals, e.g. the Argus® II retinal prosthesis system. On the other hand the best method and precisely the very common approach is the number of screen collection or shots with the help of subject’s and its vision functions (the cornea and lens) to focus the captured visually get directly to the basic thread of optical electrodes, e.g. the alpha-IMS implant.

· Implants for the Bionic Body, Bionic Lens, and Artificial Eye

An estimate of 40000000 individuals across the world having problems with zero vision and on other hand 124000000 are having fragile eyesight, we can't consider it a wonder that scientists are working hard to find new in order to get back vision. A creation bionic eyes invention is one of the unique inventions in that direction.

Our aim is to build advanced artificial intelligence-based growth so that it may prove successful for individuals having zero eyesight as disabilities. However, the approaches used by various scientists to achieve this varies.

Furthermore, as opposed to any advanced biotechnology-based innovation in people who are facing hearing ear damage, retinal prostheses research innovations is only its very early stage.

Bionic eyes have multiple capabilities other than any artificial eyes. Any other type of artificial eye is not the same as a bionic eye. Prosthetic/Artificial eyes (also known as "glass eyes" or "artificial eyes") are artificial eyes that change the appearance and design of a natural eye which has been exchanged due to some damage, discomfort or any unwanted allergy or disease. Bionic eye replacement, on the other hand, are technically fixed within the core natural structure of the brain. They're created to help you reach practical vision objectives rather than unnatural or traditional ones.

General Questions

1. Who will be taking advantages with the latest discovery of the bionic eyes that have been found very productive?

Only one applicable to user and viable bionic eye devices has been sanctioned by the FDA in the United States. That approved instrument, known as the Argus II Retinal Prosthesis System, was produced by Second Sight Medical Products, a company based in California.

2. How do retinal biotechnology-based surgeries or replacements help you see again?

The Argus II is a kind of two-part device which consists of a very micro focused camera which gets fixed on the glasses and a tiny multiple fiber type array of charged electrodes, which been fixed at the rear side of the eyes, on the front ends of the retina.

Bionic Eyes Have Certain Drawbacks

While the Argus II method allows individuals in order to distinguish color, displacements, & various figures, such innovations do not guarantee the restoration vision with the extent of what many affected people would like to happen post treatment. This type of new transplant has just 60 electrodes, which adds to this restriction. You'd require around a million of such electrodes to see the surrounding things naturally like common eyes.

Bionic Eyes in the Future

The magazine has been printed in the Second Sight opened up in 2020th that it has formulated much awaited funding to process its ongoing research plans and develop the niche Orion Visual Cortical Prosthesis Device. “An embedded cortical stimulation system designed to provide very necessary artificial eyesight to individuals who lost their vision in any type of accidents or by naturally multiple causes, including glaucoma, diabetic retinopathy, optical nerve system damage or dysfunctional disease, and eye injury,” the said company says of the current Orion bionic eye device.

Case Study of Laura Matson

Laura Matson loves life, her family, reading the Wall Street Journal and watching professional hockey. And now she likes to carry FEI brochures in her purse and tell people about her miracle. In March 2015, Matson woke up and everything looked cloudy. “It was like there was a hand in front of my face. I was fearful,” she said. She rapidly lost vision. She couldn’t work. She couldn’t drive. She couldn’t do many of the things she enjoyed. She went to a local optometrist near her home in Elmira, New York, where she wasn’t even able to read the eye chart.

He said that it looked like someone had spilled acid in her eye. Desperate for answers, Laura was referred to a local ophthalmologist, in whom she had complete trust. He recognized that Laura had a corneal injury to her left eye that had become infected, immediately prescribed drugs that might help relieve her symptoms, and began to treat her with powerful antibiotics.

Before her vision worsened, she used to walk around Syracuse by herself aided with a white cane. I would love to return to that, but I'll take what I can get," she said prior to her surgery. Rahman is the first person in New York to receive the FDA-approved Argus II Retinal Prosthesis System.

There are hardly less than 100 people in the U.S. that have the device, designed for people who have lost their vision as a result of retinitis pigmentosa. SCEI's Associate Director of Ophthalmology, Rohit Varma, MD, and team performed the surgery in late August and activated Matson struggled with infections and the corneal surface developed a severe ulcer. To treat her cornea, he sewed her eyelid shut (called a tarsorrhaphy) to protect it and let it heal. When the sutures were removed, the eye was still infected and getting worse. In the meantime, her right eye had also become infected. Understanding the seriousness of the situation, her ophthalmologist sent her to Southern California Eye Institute where she was seen by the Ophthalmologist and Physician-Scientist, Founder of Southern California Eye Institute Dr. Rohit Varma, MD, Matson was sensitive to light and in pain.

During the next months, she would be a frequent visitor to SCEI. She was given different combinations of topical and systemic antibiotics to quiet the infections. “My ophthalmologist at home – who was following me and was in constant contact with SCEI – was impressed with the treatment I received,” Matson said. “But he also commented that he thought I would never see perfectly out of the left eye again.”